AnaptysBio, Inc. (ANAB) — Financial statements
Income statement, balance sheet, and cash flow for AnaptysBio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 235↑157.0% | 91↑432.0% | 17↑66.8% | 10↓83.7% | 63 | |
| Cost of Revenue | 2↓98.5% | 164↑23.9% | 132↑49.0% | 89↓9.8% | 98 | |
| Gross Profit | 232↑420.0% | -73↑37.0% | -115↓46.6% | -79↓122.3% | -35 | |
| Operating Expenses | ||||||
| R&D Expenses | 136↓17.0% | 164↑17.3% | 140↑57.2% | 89↓9.8% | 98 | |
| General & Administrative Expenses | 51↑19.7% | 42↑1.1% | 42↑14.5% | 37↑70.5% | 21 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 51↑19.7% | 42↑1.1% | 42↑14.5% | 37↑70.5% | 21 | |
| Other Expenses | -2↑98.5% | -164↓23.9% | -132↓49.0% | -89↑9.8% | -98 | |
| Operating Expenses | 184↑334.7% | 42↓14.0% | 49↑34.5% | 37↑70.5% | 21 | |
| Total Costs & Expenses | 187↓9.5% | 206↑13.6% | 182↑44.7% | 125↑4.5% | 120 | |
| Operating Results | ||||||
| Operating Income | 48↑141.7% | -115↑30.1% | -164↓42.8% | -115↓102.7% | -57 | |
| Depreciation & Amortization | 2↑1.1% | 2↑267.6% | 0.65↓72.1% | 2↑11.7% | 2 | |
| EBITDA | 50↑154.3% | -93↑40.7% | -156↓48.6% | -105↓89.0% | -56 | |
| EBIT | 48↑150.3% | -95↑39.4% | -157↓46.0% | -108↓86.2% | -58 | |
| Interest & Other Income | ||||||
| Net Interest Income | -66↓119.2% | -30↓3934.6% | 0.79↑105.8% | -14↓1230.5% | -1 | |
| Interest Income | 13↓31.8% | 20↑4.9% | 19↑150.0% | 8↑1651.7% | 0.43 | |
| Interest Expense | 80↑59.5% | 50↑177.0% | 18↓14.3% | 21↑1355.7% | 1 | |
| Non-Operating Income | 0.00↑100.0% | -20↓169.9% | -7↑2.9% | -8↓870.1% | 0.98 | |
| Other Income / Expenses | -61↓101.3% | -30↓3942.5% | 0.79↑105.8% | -14↓1279.4% | -0.98 | |
| Income Before Tax | -13↑91.0% | -145↑11.2% | -164↓27.1% | -129↓122.7% | -58 | |
| Income Tax Expense | 0.16↑5366.7% | 0.00↑175.0% | -0.00↓116.7% | 0.02 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -13↑90.9% | -145↑11.2% | -164↓27.1% | -129↓122.7% | -58 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -13↑90.9% | -145↑11.2% | -164↓27.1% | -129↓122.7% | -58 | |
| Bottom-Line Net Income | -13↑90.9% | -145↑11.2% | -164↓27.1% | -129↓122.7% | -58 | |
| EPS (Basic) | -0.46↑91.0% | -5.12↑15.8% | -6.08↓33.0% | -4.57↓116.6% | -2.11 | |
| EPS (Diluted) | -0.46↑91.0% | -5.12↑15.8% | -6.08↓33.0% | -4.57↓116.6% | -2.11 | |
| Weighted Average Shares | 28↓2.1% | 28↑5.4% | 27↓4.4% | 28↑2.7% | 27 | |
| Weighted Average Diluted Shares | 31↑10.4% | 28↑5.4% | 27↓4.4% | 28↑2.7% | 27 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.